Ardena
Drug product development, nanomedicine and bioanalytical services for biopharma developers working with complex molecules
Highlights
- Hiring19 open roles
- New on EvolcAdded 2026-10-24
About Ardena
Ardena is a CDMO and bioanalytical CRO. It develops and manufactures drug products, including sterile and non-sterile dosage forms, and covers nanomedicine from building block synthesis through GMP production and regulatory support. Its bioanalytical services include analytical method development and stability programs.
Its clients are biopharma innovators developing complex molecules, including highly potent APIs, controlled substances and targeted therapies. Services span formulation, analytical development, GMP manufacturing, clinical trial supplies and stability studies.
Ardena is headquartered in Ghent, Belgium, and also operates sites in Somerset, New Jersey, and Pamplona, Spain. The company reports 700+ employees across five facilities in Europe and the US. Current job openings cover production, quality assurance, CMC regulatory writing, research and development, finance and IT.
Product: Contract drug product development and GMP manufacturing, nanomedicine development, and bioanalytical CRO services
Jobs at Ardena (19)
Ardena is hiring for 19 roles, mostly in manufacturing, based in Ghent and Somerset.
Data & BI Engineer (Microsoft Fabric / Power BI)
New on EvolcQualified Person
New on EvolcAccountant (A-Z) - Controller
New on EvolcAssociate Group Leader Analytical Development
New on EvolcAssociate Director, Finance
New on EvolcPharmaceutical Technician I
New on EvolcMaster Planner
New on Evolc
Companies hiring like Ardena
Leadership
- Jeremie Trochu · Chief Executive OfficerSource: company website
- Ben Ash · Chief Financial Officer (CFO)Source: company website
- Henny Zijlstra · Chief Commercial Officer (CCO)Source: company website
- Anita Knapper · Head of HR NetherlandsSource: company website
More biotech & pharma companies
Argenx
Develops and commercializes antibody medicines for patients with autoimmune and neuromuscular diseasesNew on EvolcSalary transparentArecor
Develops therapeutics for people with diabetes, obesity and other cardiometabolic diseasesNew on EvolcArevipharma
CGMP pharmaceutical ingredients and contract manufacturing for global pharmaceutical companiesNew on EvolcArtbio
Develops alpha radioligand cancer therapies for patients; lead prostate cancer candidate AB001 is in Phase 1 trialsNew on EvolcArtidis
Nanomechanical cancer research devices and data software for researchers, laboratories and clinical investigatorsAscendis Pharma
Biopharmaceutical company developing rare endocrine and oncology therapies on its TransCon platform for patients and physicians
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
CRM & customer data
- HubSpotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.